Skip to main content
. 2016 Aug 3;1(4):221–229. doi: 10.1016/j.ekir.2016.07.008

Table 1.

Characteristics of liver transplant candidates before propensity score matching by transplant type (UNOS data between 2003 and 2013 in the USA)

N LTA SLK P value
N = 35,947 34,337 1610
Age (yr)a 35,947 52.6 ± 10 54.3 ± 9.6 <0.001
Gender (female, %)a 35,947 33.9 34.1 0.84
Race (AA, %)a 35,947 8.9 15.3 <0.001
Recipient DM (%)a 35,947 23.5 37 <0.001
Liver disease (%)a 35,947 <0.001
 HCV infection 27.8 28.6
 ETOH and NASH 23.6 23.4
 Cholestatic 10.9 7
 Others 37.6 40.1
BMIa 35,919 28.3 ± 5.8 27.4 ± 5.8 <0.001
Scr (mg/dl) at transplant (if not on dialysis)a 34,403 1.5 ± 1 3 ± 1.2 <0.001
eGFR at transplant (ml/min per 1.73 m2)b 34,403 62.9 ± 32.5 26.9 ± 17.2 <0.001
INR at transplanta 35,947 2 ± 1.2 1.9 ± 0.9 <0.001
Total bilirubin (mg/dl) at transplanta 34,258 10.7 ± 12 12.4 ± 14.5 <0.001
On dialysis at transplant (%) 35,947 8.6 50 <0.001
MELD at transplant 35,944 24.2 ± 9.2 30.9 ± 8.4 <0.001
Liver DRIa 30,982 1.4 ± 0.4 1.2 ± 0.3 <0.001
Median time to transplant (25th and 75th percentiles), moa 35,946 1.9 (0.4, 6.8) 1.3 (0.4, 5.2) 0.001

± Denotes 1 SD.

AA, African American; BMI, body mass index; DM, diabetes; DRI, donor risk index; eGFR, estimated glomerular filtration rate; ETOH and NASH, alcohol and nonalcoholic steatohepatitis; HCV, hepatitis C virus; INR, international normalized ratio; LTA, liver transplant alone; MDRD, Modification of Diet in Renal Disease Study; MELD, model for end-stage liver disease; N, sample size; Scr, serum creatinine; SLK, simultaneous liver-kidney transplantation; UNOS, United Network for Organ Sharing.

a

The variables used in the propensity score matching.

b

The MDRD 4-variable equation to eGFR, calculated for the recipient who was not on dialysis.